- 专利权人:
- NOVARTIS AG
- 发明人:
- DONALD JOHNS,KLAUS KUCHER,GEORGE IMBERT
- 申请号：
- MX2014002693
- 公开号：
- MX2014002693A
- 申请日:
- 2011.09.07
- 申请国别(地区):
- MX
- 年份:
- 2014
- 代理人:
- 摘要：
- The invention concerns the use of competitive AMPA receptor antagonists for the treatment or prevention of photosensitive epilepsy.La invención se refiere al uso de antagonistas competitivos de los receptores de AMPA para el tratamiento o la prevención de epilepsia fotosensible.
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- USE OF 1H-QUINAZOLINE- 2, 4 -DIONES FOR USE IN THE PREVENTION OR TREATMENT PHOTOSENSITIVE EPILEPSY
- Use of 1H-quinazoline- 2, 4 -diones for use in the prevention or treatment photosensitive epilepsy
- USE OF 1H-QUINAZOLINE- 2, 4 -DIONES FOR USE IN THE PREVENTION OR TREATMENT PHOTOSENSITIVE EPILEPSY
- 광민감성 간질의 예방 또는 치료에 사용하기 위한 1H-퀴나졸린-2,4-디온의 용도
- Use of 1H-quinazoline-2,4-diones
